Literature DB >> 33335697

Hepatopulmonary Syndrome and Post-Liver Transplantation Complications: A Case-Control Study.

A Morvan1, M Gazon1, S Duperret1, Z Schmitt1, P Pradat2, K Mohkam3, F Aubrun1.   

Abstract

BACKGROUND: Although liver transplantation (LT) improves survival in cirrhotic patients with hepatopulmonary syndrome (HPS), few data exist concerning post-operative complications in these patients.
OBJECTIVE: To compare complications after LT between patients with and without HPS.
METHODS: In a case-control study, we retrospectively analyzed all patients who underwent LT in our center from January 2010 to July 2016. We compared cases of identified HPS to controls matched for age, MELD score, comorbidities, red blood cells transfused, and highest dosage of norepinephrine perfused during transplantation.
RESULTS: Among 451 transplanted patients, we identified 71 patients with HPS who could be analyzed. We found a significantly (p<0.001) higher number of post-operative complications in patients with HPS (median 5 vs 3), with more occurrence of cardiac, infectious and surgical complications than in the controls: 39.4% vs 12.7% (p<0.001), 81.7% vs 49.3% (p<0.001), and 59.2% vs 40.1% (p<0.029), respectively. There were also more ICU readmissions at 1 month among HPS patients (10 vs 1, p=0.01). There was no significant difference concerning ventilation data, lengths of ICU or hospital stay (8.5 [range 3-232] and 32 [14-276] days, respectively on the whole cohort) and death in the ICU (4.2% on the whole cohort). The 1-year survival was higher in HPS patients (94.4% vs 81.1%, p=0.034); there was no difference in 5-year survival.
CONCLUSION: HPS patients seem to have a higher number of complications in the first month following LT.

Entities:  

Keywords:  Hepatopulmonary syndrome; Liver cirrhosis; Liver transplantation; Post-operative complications

Year:  2020        PMID: 33335697      PMCID: PMC7726840     

Source DB:  PubMed          Journal:  Int J Organ Transplant Med        ISSN: 2008-6482


  28 in total

1.  Living-related liver transplantation in patients with pulmonary vascular disease.

Authors:  H Kikuchi; N Ohkohchi; T Orii; S Satomi
Journal:  Transplant Proc       Date:  2000-11       Impact factor: 1.066

Review 2.  Pulmonary-Hepatic vascular Disorders (PHD).

Authors:  R Rodríguez-Roisin; M J Krowka; Ph Hervé; M B Fallon
Journal:  Eur Respir J       Date:  2004-11       Impact factor: 16.671

3.  Sustained low diffusing capacity in hepatopulmonary syndrome after liver transplantation.

Authors:  Graciela Martínez-Palli; Federico P Gómez; Joan A Barberà; Miquel Navasa; Josep Roca; Robert Rodríguez-Roisin; Felip Burgos; Conchi Gistau
Journal:  World J Gastroenterol       Date:  2006-09-28       Impact factor: 5.742

4.  Liver transplantation for hepatopulmonary syndrome: a ten-year experience in Paris, France.

Authors:  Camille Taillé; Jacques Cadranel; Agnès Bellocq; Gabriel Thabut; Olivier Soubrane; François Durand; Philippe Ichaï; Christophe Duvoux; Jacques Belghiti; Yvon Calmus; Hervé Mal
Journal:  Transplantation       Date:  2003-05-15       Impact factor: 4.939

5.  Severe hypoxia and malnutrition collectively contribute to scar fibroblast inhibition and cell apoptosis.

Authors:  Emily C Lynam; Yan Xie; Rebecca Dawson; Jacqui Mcgovern; Zee Upton; XiQiao Wang
Journal:  Wound Repair Regen       Date:  2015-09-22       Impact factor: 3.617

6.  Comparison of transesophageal and transthoracic contrast echocardiography for detection of an intrapulmonary shunt in liver disease.

Authors:  J M Vedrinne; S Duperret; T Bizollon; C Magnin; J Motin; C Trepo; C Ducerf
Journal:  Chest       Date:  1997-05       Impact factor: 9.410

7.  Prevalence and reversibility of the hepatopulmonary syndrome after liver transplantation. The Cleveland Clinic experience.

Authors:  J K Stoller; P A Lange; M K Westveer; W D Carey; D Vogt; J M Henderson
Journal:  West J Med       Date:  1995-08

8.  Occurrence of hepatopulmonary syndrome in patients with cirrhosis who are candidates for liver transplantation.

Authors:  Liana Gonçalves Macêdo; Edmundo Pessoa de Almeida Lopes; Maria de Fátima Pessoa Militão de Albuquerque; Brivaldo Markman-Filho; Flávio Henrique Amaral Pires Véras; Ana Carolina Chiappetta Correia de Araújo; Alvaro Antônio Bandeira Ferraz
Journal:  J Bras Pneumol       Date:  2010 Jul-Aug       Impact factor: 2.624

9.  Natural history of hepatopulmonary syndrome: Impact of liver transplantation.

Authors:  Karen L Swanson; Russell H Wiesner; Michael J Krowka
Journal:  Hepatology       Date:  2005-05       Impact factor: 17.425

10.  Hepatopulmonary syndrome and portopulmonary hypertension: a report of the multicenter liver transplant database.

Authors:  Michael J Krowka; M Susan Mandell; Michael A E Ramsay; Steve M Kawut; Michael B Fallon; Cosme Manzarbeitia; Manuel Pardo; Paul Marotta; Shinji Uemoto; Markus P Stoffel; Joanne T Benson
Journal:  Liver Transpl       Date:  2004-02       Impact factor: 5.799

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.